Skip to search formSkip to main contentSkip to account menu

SAMARIUM Sm153

Known as: Samarium, Isotope of Mass 153, SAMARIUM SM-153, Sm-153 
A radioactive substance used in the treatment of bone cancer and bone metastases (cancers that have spread from the original tumor to the bone… 
National Institutes of Health

Related topics

Related topics

3 relations

Narrower (1)

Quadramet
SAMARIUM Sm153 50 MCI/ML Injectable Solution [Quadramet]

Broader (1)

Samarium

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
WITHDRAWN: Radioisotopes for metastatic bone pain.
BACKGROUND This is an update of the review published in Issue 4, 2003. Bone metastasis cause severe pain as well as pathological… 
2008
2008
Chemical and biological evaluation of 153Sm and 166Ho complexes of 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrakis(methylphosphonic acid monoethylester) (H4 dotp OEt).
Highly Cited
2004
Highly Cited
2004
Samarium — 153 EDTMP therapy of disseminated skeletal metastasis
Abstract153Sm-EDTMP (ethylenediaminetetramethylene phosphonate), prepared from a kit, was administered to 28 patients in a… 
2003
2003
Progressive studies on the novel samarium-catalyzed diastereoselective tandem semipinacol rearrangement/Tishchenko reduction of secondary alpha-hydroxy epoxides.
A novel and highly diastereoselective samarium-catalyzed tandem rearrangement/reduction of secondary alpha-hydroxy epoxides… 
Highly Cited
2000
Highly Cited
2000
Considerations in the selection of radiopharmaceuticals for palliation of bone pain from metastatic osseous lesions.
UNLABELLED Bone pain is a common complication for terminal patients with bone metastases from prostate, lung, breast, and other… 
Highly Cited
1999
Highly Cited
1999
Tetrametallic Reduction of Dinitrogen: Formation of a Tetranuclear Samarium Dinitrogen Complex.
The cooperative attack of four (dipyrromethanyl)Sm(II) units on dinitrogen resulted in a novel tetranuclear samarium dinitrogen… 
Review
1996
Review
1996
Radioimmunotherapy of solid cancers: A review.
Depending on radionuclide characteristics, radioimmunotherapy (RIT) relies on radioactivity to destroy cells distant from… 
1996
1996
Maxillectomy and targeted radionuclide therapy with 153Sm-EDTMP in a recurrent canine osteosarcoma.
An eight-year-old dog with a local relapse of an osteosarcoma was treated with partial maxillectomy and systemic radionuclide… 
1994
1994
Comparison of biological characteristics of EDTMP complexes with 99mTc, 111In and 153Sm in rats.
1986
1986
153Sm radiotherapeutic bone agents.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)